International Business Machines Corporation IBM SPXAI
Company Overview
International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers hybrid cloud and AI platforms that allow clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment delivers strategy and technology services and intelligent operations, providing business transformation, technology implementation, managed services, application modernization, and AI-powered solutions. The Infrastructure segment provides on-premises and cloud-based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. Its Financing segment offers client and commercial financing, and facilitates IBM clients' acquisition of hardware, software, and services. It has strategic partnerships with various companies, including hyperscalers, service providers, global system integrators, and software and hardware vendors that include Adobe, Amazon Web Services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. Additionally, the company operate a data streaming platform. The company has a strategic collaboration with Arm Holdings plc for the development of new dual-architecture hardware that helps enterprises run future AI and data intensive workloads; and strategic partnership with three.ws to advance ai-powered 3d agent technology. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.
Why Investors Should Care
Generates a return on equity of 35.8%, reflecting efficient use of shareholder capital.
Trades at a P/E of 19.2, below the sector median of 36.0.
Maintains a net profit margin of 15.6%.
Offers a dividend yield of 2.48%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $67.53B (+7.6% YoY); net profit $10.59B.
- Trailing 12 Months Year-on-year growth — revenue +9.5%, earnings +14.2%.
- 5-Year Trend Long-term compounding — revenue CAGR -2.1%, profit CAGR -0.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -2.09% |
| 1 Year: | 9.50% |
Compounded Profit Growth
| 5 Years: | -0.89% |
| 1 Year: | 14.20% |
Stock Price Performance
| 1 Year: | -21.55% |
| 6 Months: | -27.71% |
| 3 Months: | -8.05% |
| 1 Month: | -21.02% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
watsonx platform, Granite open models, Red Hat OpenShift AI; Concert/Apptio Software acquisitions.
- watsonx platform IBM's watsonx is an enterprise AI/data platform for building, governing and deploying models — with a multi-billion-dollar GenAI book of business across software and consulting.
- AI consulting IBM Consulting helps enterprises deploy GenAI, a large services growth driver.
- Hybrid-cloud + Red Hat AI Red Hat OpenShift AI enables enterprises to run AI across hybrid environments.
- Enterprise/governed-AI play combining watsonx software with deep consulting reach.
- Strong free cash flow and ROE ~36% fund a high dividend.
- GenAI bookings provide a growing, visible pipeline.
- Slow overall growth (~10%) means AI must move the needle on a large base.
Curated from public filings and analyst commentary; figures are illustrative.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 35.8%.
- Generates positive free cash flow.
CONS
- Revenue declined at -2.1% CAGR over 5 years.
- Earnings shrank at -0.9% CAGR over 5 years.
- Trading 34.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | IBM International Business Machines Corporation SPXAI | 217.07 | 19.21 | $204.02B | 2.48% | - | 35.77% | -2.09% | -0.89% |
| 2 | NVDA NVIDIA Corporation NDXSPXAI | 211.80 | 32.43 | $5.13T | 0.49% | 74.66% | 114.29% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPX | 314.86 | 38.07 | $4.62T | 0.37% | 68.72% | 141.47% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXAI | 384.93 | 22.91 | $2.86T | 0.93% | 26.90% | 34.01% | 9.48% | 10.85% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AI | 420.39 | 36.18 | $2.18T | 0.90% | 30.20% | 36.21% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXAI | 389.11 | 64.85 | $1.85T | 0.68% | 16.70% | 37.28% | 24.38% | 26.24% |
| 7 | MU Micron Technology, Inc. NDXSPXAI | 983.12 | 46.37 | $1.11T | 0.06% | 13.69% | 39.82% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXAI | 548.13 | 181.50 | $893.78B | 0.00% | 6.33% | 8.06% | 13.64% | 48.64% |
| 9 | ASML ASML Holding N.V. NDXAI | 1,775.64 | 59.55 | $684.36B | 0.47% | 42.97% | 52.24% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.41B | 24.92B | 23.34B | 22.24B | 24.05B | 22.40B | 19.59B | 20.81B | 19.28B | 18.68B | 20.24B | 19.23B | 18.16B | 19.29B | 19.15B | 19.07B | 20.00B | 18.76B | 18.18B | 19.16B | 18.03B | 17.57B | 18.12B | 17.56B | 13.19B | 14.22B | 13.25B | 14.20B | 15.54B | 14.11B | 14.25B | 15.47B | 14.75B | 14.46B | 15.77B | 14.97B | 14.54B | 16.98B | 16.33B | 15.92B |
| Gross Profit | 10.68B | 12.13B | 11.43B | 10.63B | 12.04B | 10.87B | 9.45B | 10.39B | 9.44B | 8.69B | 9.70B | 9.01B | 7.94B | 8.97B | 8.98B | 8.25B | 9.20B | 8.80B | 8.04B | 9.01B | 8.34B | 7.92B | 8.70B | 8.43B | 7.03B | 7.85B | 7.11B | 7.33B | 8.29B | 7.43B | 7.51B | 8.50B | 8.02B | 7.74B | 8.95B | 8.42B | 8.03B | 9.98B | 9.36B | 8.95B |
| Net Income | - | - | - | - | - | - | - | - | - | 2.01B | 2.50B | 2.85B | 1.75B | 2.33B | 2.73B | 1.68B | 2.40B | 2.69B | 1.59B | 2.50B | 1.67B | 1.18B | 1.36B | 1.70B | 955.00M | 1.32B | 1.13B | 733.00M | 1.39B | -3.20B | 927.00M | 1.58B | 1.70B | 1.60B | 1.83B | -330.00M | 1.05B | 2.19B | 1.74B | 1.22B |
| Diluted EPS | 2.70 | 2.91 | 3.68 | 2.29 | 4.12 | 0.02 | 2.35 | 3.50 | 3.01 | 2.09 | 2.61 | 2.98 | 1.85 | 2.48 | 2.92 | 1.81 | 2.61 | 2.94 | 1.78 | 2.81 | 1.87 | 1.31 | 1.52 | 1.89 | 1.06 | 1.47 | 1.25 | 0.81 | 1.53 | -3.54 | 1.01 | 1.72 | 1.84 | 1.72 | 1.96 | -0.36 | 1.12 | 2.31 | 1.84 | 1.28 |
| R&D Expense | 1.64B | 1.55B | 1.36B | 1.40B | 1.36B | 1.35B | 1.30B | 1.30B | 1.29B | 1.46B | 1.47B | 1.40B | 1.48B | 1.44B | 1.29B | 1.41B | 1.36B | 1.25B | 1.43B | 1.41B | 1.55B | 1.62B | 1.58B | 1.51B | 1.62B | 1.64B | 1.61B | 1.68B | 1.67B | 1.61B | 1.66B | 1.69B | 1.69B | 1.80B | 1.84B | 1.88B | 1.95B | 2.10B | 2.08B | 2.17B |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 98.79B | 103.63B | 95.76B | 99.87B | 106.92B | 102.87B | 98.37B | 92.79B | 81.74B | 79.92B | 79.14B | 79.59B | 57.71B | 55.18B | 57.35B | 60.53B | 61.86B | 62.75B | 67.53B |
| Gross Profit | 41.73B | 45.66B | 43.78B | 46.01B | 50.14B | 50.36B | 48.68B | 46.41B | 40.68B | 38.52B | 36.94B | 36.94B | 31.53B | 30.86B | 31.49B | 32.69B | 34.30B | 35.55B | 39.30B |
| Net Income | - | 12.33B | 13.43B | 14.83B | 15.86B | 16.60B | 16.48B | 12.02B | 13.19B | 11.87B | 5.75B | 8.73B | 9.43B | 5.59B | 5.74B | 1.64B | 7.50B | 6.02B | 10.59B |
| Diluted EPS | 7.15 | 8.89 | 10.01 | 11.52 | 13.06 | 14.37 | 14.94 | 11.90 | 13.42 | 12.38 | 6.14 | 9.52 | 10.56 | 6.23 | 6.35 | 1.80 | 8.14 | 6.43 | 11.17 |
| R&D Expense | 6.15B | 6.34B | 5.82B | 6.03B | 6.26B | 5.82B | 5.74B | 5.44B | 5.25B | 5.73B | 5.59B | 5.38B | 5.91B | 6.26B | 6.49B | 6.57B | 6.78B | 7.48B | 8.32B |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 109.52B | 109.02B | 113.45B | 116.43B | 119.21B | 125.64B | 117.27B | 110.50B | 117.47B | 125.36B | 123.38B | 152.19B | 155.97B | 132.00B | 127.24B | 135.24B | 137.18B | 151.88B |
| Total Equity | 28.64B | 28.61B | 13.46B | 22.64B | 23.05B | 20.14B | 18.86B | 22.79B | 11.87B | 14.26B | 18.25B | 17.59B | 16.80B | 20.84B | 20.60B | 18.90B | 21.94B | 22.53B | 27.31B | 32.65B |
| Cash & Equivalents | 8.02B | 14.99B | 12.74B | 12.18B | 10.66B | 11.92B | 10.41B | 10.72B | 8.48B | 7.69B | 7.83B | 11.97B | 11.38B | 8.17B | 13.19B | 6.65B | 7.89B | 13.07B | 13.95B | 13.59B |
| Long Term Debt | - | - | - | 24.15B | 21.85B | 22.86B | 24.09B | 32.86B | 34.99B | 33.43B | 34.66B | 39.84B | 35.60B | 54.10B | 54.22B | 44.92B | 46.19B | 50.12B | 49.88B | 54.84B |
| Total Liabilities | - | - | 95.94B | 86.27B | 90.28B | 96.20B | 100.23B | 103.29B | 105.26B | 96.07B | 99.08B | 107.63B | 106.45B | 131.20B | 135.24B | 113.00B | 105.22B | 112.63B | 109.78B | 119.14B |
| Current Liabilities | - | - | 42.44B | 36.00B | 40.56B | 42.12B | 43.62B | 40.15B | 39.58B | 34.27B | 36.27B | 37.36B | 38.23B | 37.70B | 39.87B | 33.62B | 31.50B | 34.12B | 33.14B | 38.66B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | 18.81B | 20.77B | 19.55B | - | - | - | 16.87B | 17.25B | 17.08B | 16.72B | 15.25B | 14.77B | 18.20B | 12.80B | 10.44B | 13.93B | 13.45B | 13.19B |
| Investing Cash Flow | - | -9.29B | -6.73B | -8.51B | - | - | - | -3.00B | -8.16B | -10.93B | -7.08B | -4.91B | -26.94B | -3.03B | -5.97B | -4.20B | -7.07B | -4.94B | -10.30B |
| Financing Cash Flow | - | -11.83B | -14.70B | -12.43B | - | - | - | -15.45B | -9.41B | -5.92B | -6.42B | -10.47B | 9.04B | -9.72B | -13.35B | -4.96B | -1.77B | -7.08B | -3.83B |
| Capital Expenditure | -4.63B | -4.17B | -3.45B | -4.18B | -4.11B | -4.08B | -3.62B | -3.74B | -3.58B | -3.57B | -3.23B | -3.40B | -2.29B | -2.62B | -2.06B | -1.35B | -1.25B | -1.05B | -1.09B |
| Free Cash Flow | - | 14.64B | 17.33B | 15.36B | - | - | - | 13.13B | 13.68B | 13.52B | 13.49B | 11.85B | 12.48B | 15.58B | 10.73B | 9.09B | 12.69B | 12.40B | 12.10B |
| Share Buybacks | 18.83B | 10.58B | 7.43B | 15.38B | 15.05B | 11.99B | 13.86B | 13.68B | 4.61B | 3.50B | 4.34B | 4.44B | 1.36B | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 42.2% | 44.1% | 45.7% | 46.1% | 46.9% | 49.0% | 49.5% | 50.0% | 49.8% | 48.2% | 46.7% | 46.4% | 54.6% | 55.9% | 54.9% | 54.0% | 55.4% | 56.7% | 58.2% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Margin % | - | 11.9% | 14.0% | 14.9% | 14.8% | 16.1% | 16.8% | 13.0% | 16.1% | 14.9% | 7.3% | 11.0% | 16.3% | 10.1% | 10.0% | 2.7% | 12.1% | 9.6% | 15.7% |
| ROE % | - | 91.6% | 59.3% | 64.4% | 78.7% | 88.0% | 72.3% | 101.3% | 92.5% | 65.1% | 32.7% | 52.0% | 45.3% | 27.1% | 30.4% | 7.5% | 33.3% | 22.1% | 32.4% |
| ROCE % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 8.25% | 77.57M | $23.29B |
| 2 | Vanguard Capital Management LLC | 6.47% | 60.85M | $18.27B |
| 3 | State Street Corporation | 5.81% | 54.59M | $16.39B |
| 4 | Vanguard Portfolio Management LLC | 2.94% | 27.66M | $8.30B |
| 5 | Geode Capital Management, LLC | 2.46% | 23.08M | $6.93B |
| 6 | Morgan Stanley | 2.09% | 19.63M | $5.89B |
| 7 | JPMORGAN CHASE & CO | 1.97% | 18.54M | $5.57B |
| 8 | Capital World Investors | 1.82% | 17.06M | $5.12B |
| 9 | Bank of America Corporation | 1.71% | 16.06M | $4.82B |
| 10 | Northern Trust Corporation | 1.10% | 10.30M | $3.09B |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for IBM
IBM stock closes down more than 25% after preannounced earnings results - Yahoo Finance
<ol><li><a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNa1B6RGR4bEJndFU1eTRNSW0zSlB0VmIyWnhyUE4xWGM4YkxtUU9Bemt2UEkyRzg5Wl9IZGd5OWl1cEJiMmlZbVhKYTZaTy1ZOUFzTDE5VHZUUVpfLUNqNUFkclRIZUp2bVBnOTE0VGRlYkhQN1RTOV92Z3lHX1NHa0k0eWpVTz…
Stock Market Today: Nasdaq Leads The Day; Yum Brands Falls On Report Of Taco Bell Investigation (Live Coverage) - Investor's Business Daily
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNczZyN2k2YThlSG5TSHN2RHlSM1BKSUFkMlN1V3lEUXpPdm5TUDltNnJUVU5aLW5NWTJKX1pQb0VKRGVZcHlRdlFGd3pWQjNHWDFJc3lsb1JYWXFvMklMYlVSdnhQVENndk5vMU9VYVJPYXMtZXRxeGhERkdpSWFUTTJNY2dWNnJSYmdFY2…
Why IBM Stock Crashed Today - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPdDY5VUlwallac0RFRkVTLXFTdkZyQTNnLTFwS3gteTI5YlBNUFBoU3pXVmhyaXJOVDMzLUVrbnQ2dlVpYl9GZG41TWsyQkNUMlhlQ0dXWlJudmk2NTZ3NV9uT1pzSzNiX08yQWRkWm9uZlNVcmtRNVFJem5uQlZNUWhFemMtVFVra083Ql…
IBM stock craters 25%, the worst day on record, after company issues second-quarter earnings warning - CNBC
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOS3RmR3lfZGZlSjVwa19WeWtzV0N2WTZKTUlDRlpTS1BjWl9kVU9YWGdEZ0ZPQy1LNkltVkxlb0U1ZUFjcHN6M2lvNFRSVThXSFNQVnBnSWh0Sm52SmVmREtiN1dQRjEtM0hqYTdScFN2NGwyMEVzNXlxR2NKc2N0MVNMQnRqNUdWaWNsdk…
Why IBM Stock Crashed Today - The Motley Fool
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTFBOakVwRVVNR19WaE9zWGNvX2l2d2hYaWxZV3dvcVNnODhFTjQzeGczaGNIZ0xGX091UGVHUVZScXhsQWcxZEF0WHJ4SlBIUGFvSFNmOEQ1TVF6bmhzeGtRdkxyLWxUcy1lc0FVT2xPLXVHZ0hVQkgwMUh3?oc=5" target="_blank">Why…
IBM Suffers Biggest Share Drop in Its History - WSJ
<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxPcHlKcWI0bUM3eW5sMkVzT0ppNlVoTmdNYXgwR0kzOXlvM2xWeUpTem1LdlRjZzZCR01GVFduRWFLenAyQXE2Qm1QWGNRZW9sOWlseTl1RVNpSTZTc3dyZUJRZUJvQS1QUFE1RFhJOU1zdHJZbWIxQVZka190TzVlWWhuaW5DaEN3TVE?oc…
IBM — Frequently Asked Questions
What is the current share price of International Business Machines Corporation (IBM)?
As of 2026-07-14 21:23 PDT, International Business Machines Corporation (IBM) trades at $217.07 on NYSE. Its 52-week range is $214.64 to $329.23.
What is the market capitalisation of IBM?
International Business Machines Corporation (IBM) has a market capitalisation of $204.02B on NYSE.
What is the P/E ratio of IBM?
IBM trades at a trailing price-to-earnings (P/E) ratio of 19.21. The industry average P/E is 36.02. Its price-to-book (P/B) ratio is 7.76.
Does IBM pay a dividend?
International Business Machines Corporation (IBM) currently offers a dividend yield of 2.48%.
What is the return on equity (ROE) of IBM?
IBM has a return on equity (ROE) of 35.77%.
Is IBM a good stock to buy?
This page provides a data-driven analysis of International Business Machines Corporation (IBM), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.